Nuplazid 34 MG capsule 30S
Ended Awarded Last action
- Contract number
- SPE2DR26FRRN1
- Awardee
-
DMS Pharmaceutical Group Inc. UEI PX72BSBQTKJ3
- Awarding agency
-
Defense Logistics Agency
Department of Defense
- Obligated
- $11,771
Award facts
- Contract value 100% obligated
- $11,771.46 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- NAICS code
- 424210 Drugs and Druggists' Sundries Merchant Wholesalers
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Full and Open Competition Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Place of performance
- Park Ridge, IL 60068, USA
Award details come from SAM.gov/FPDS.
About this award
The Defense Logistics Agency awarded a delivery order valued at $11,771.46 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois, for the supply of Nuplazid 34 mg capsules (30-count units). The award, issued on January 21, 2026, with an ultimate completion date of February 11, 2026, utilizes a firm fixed-price contract structure with no set-aside designation, indicating the vendor competed in an unrestricted procurement process. This delivery order is issued under DMS Pharmaceutical Group's Indefinite Delivery Contract with DLA's Pharmaceutical Prime Vendor Global Program Generation V (PPV-G GEN V) initiative, a $499.99 billion acquisition strategy that positions the company as a regional prime vendor contractor supplying pharmaceuticals to Department of Defense military healthcare facilities worldwide.
DMS Pharmaceutical Group has demonstrated substantial capability as a critical supplier within the federal pharmaceutical supply chain, with its established performance across multiple therapeutic categories and product lines supporting military medical operations. The company's portfolio encompasses branded and generic prescription medications, biologics, vaccines, and specialty pharmaceuticals, with previous delivery orders ranging from under $100 to over $115,000. As a small business contractor with SAM registration since July 2001, DMS Pharmaceutical Group leverages its status and operational capacity to compete effectively in government procurement while maintaining consistent performance on recurring medical supply requirements for the Department of Defense.
Quick answers
Who was awarded contract SPE2DR26FRRN1?
SPE2DR26FRRN1 was awarded to DMS Pharmaceutical Group Inc. by Defense Logistics Agency (Department of Defense) on January 21, 2026.
How much is contract SPE2DR26FRRN1 worth?
The government has obligated $11,771 on SPE2DR26FRRN1.
Is contract SPE2DR26FRRN1 an order under another contract?
Yes. SPE2DR26FRRN1 is a delivery order under SPE2DR25D9238, an indefinite delivery contract.
Was contract SPE2DR26FRRN1 competed?
The extent of competition for SPE2DR26FRRN1 was full and open competition.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award